hideThis article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages)
This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help by introducing citations to additional sources. Find sources: – ···scholar·JSTOR(June 2015)
The topic of this article may not meet Wikipedia's general notability guideline. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: – ···scholar·JSTOR(June 2015) (Learn how and when to remove this template message)
(Learn how and when to remove this template message)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y (what isYN ?)
Infobox references
Chemical compound
Ethylbenzodioxolylbutanamine (EBDB; Ethyl-J) is a lesser-known entactogen, stimulant, and psychedelic. It is the N-ethylanalogue of benzodioxylbutanamine (BDB; "J"), and also the α-ethyl analogue of methylenedioxyethylamphetamine (MDEA; "Eve").
EBDB was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage consumed was 90 mg, and the duration is unknown.[1] EBDB produced few to no effects at the dosage range tested in PiHKAL, but at higher doses of several hundred milligrams it produces euphoric effects similar to those of methylbenzodioxylbutanamine (MBDB; "Eden", "Methyl-J"), although milder and shorter lasting.[citation needed]
Very little data exists about the pharmacological properties, metabolism, and toxicity of EBDB.